Literature DB >> 30269801

A Review of Stem Cell Therapy for Acquired Brain Injuries and Neurodegenerative Central Nervous System Diseases.

Thomas K Watanabe1.   

Abstract

Cell-based therapies have been the subject of much discussion regarding their potential role in enhancing central nervous system function for a number of pathologic conditions. Much of the current research has been in preclinical trials, with clinical trials in the phase I or I/II stage. Nevertheless, there is considerable interest in the public about the potential regenerative role that stem cells may have in improving function for these neurologic conditions. This review will describe the different types of stem cells that are available, review their possible effects, and discuss some of the variables that investigators need to consider when designing their studies. Current clinical research in the areas of stroke, traumatic brain injury, and neurodegenerative diseases (amyotrophic lateral sclerosis and Parkinson disease) will be reviewed. As this article is aimed at a rehabilitation audience, outcome measures, and the role of concurrent rehabilitation therapies will also be mentioned.
Copyright © 2018 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30269801     DOI: 10.1016/j.pmrj.2018.07.008

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  4 in total

1.  Mechanical micronization of lipoaspirates for the treatment of hypertrophic scars.

Authors:  Jing Wang; Yunjun Liao; Jing Xia; Zijue Wang; Xiaopei Mo; Jingwei Feng; Yunfan He; Xihang Chen; Ye Li; Feng Lu; Junrong Cai
Journal:  Stem Cell Res Ther       Date:  2019-01-24       Impact factor: 6.832

Review 2.  Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System.

Authors:  Doddy Denise Ojeda-Hernández; Alejandro A Canales-Aguirre; Jorge Matias-Guiu; Ulises Gomez-Pinedo; Juan C Mateos-Díaz
Journal:  Front Bioeng Biotechnol       Date:  2020-05-05

3.  Human ESC-derived immunity- and matrix- regulatory cells ameliorated white matter damage and vascular cognitive impairment in rats subjected to chronic cerebral hypoperfusion.

Authors:  Yilong Zhao; Jun Wu; Da Li; Jing Liu; Weiqi Chen; Zongren Hou; Kailun Liu; Lingling Jiang; Xiaowei Chen; Liu Wang; Baoyang Hu; Fangrong Zong; Yukai Wang; Yilong Wang
Journal:  Cell Prolif       Date:  2022-04-19       Impact factor: 8.755

4.  Efficacy of Cell-Based Therapies for Traumatic Brain Injuries.

Authors:  Matthew R Chrostek; Emily G Fellows; Winston L Guo; William J Swanson; Andrew T Crane; Maxim C Cheeran; Walter C Low; Andrew W Grande
Journal:  Brain Sci       Date:  2019-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.